Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-Week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK study)

1. Arribas, J.R.
2. Pulido, F.
3. Delgado, R.
4. Lorenzo, A.
5. Miralles, P.
6. Arranz, A.
7. González-García, J.J.
8. Cepeda, C.
9. Hervás, R.
10. Paño, J.R.
11. Gaya, F.
12. Carcas, A.
13. Montes, M.L.
14. Costa, J.R.
15. Peña, J.M.